Corcept Therapeutics Incorporated
CORT
$116.00-0.09%
Delayed · as of Sep 28, 2026, 2:46 PM ET
Mkt cap
$7.46B
EV/Sales
9.64
P/E ratio
N/A
FY2025 Revenue
$761.41M
EPS (TTM)
$0.45
Gross Margin (FY2025)
98.30%
Profit Margin (FY2025)
13.09%
Beta
0.35
Div yield
N/A
Sector
Healthcare
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported CORT revenue for 2025-12-31 was $761.4M. Net income was $99.7M. Revenue was up 12.8% from 2024-12-31 to 2025-12-31. CORT currently screens at market cap $7.46B.
Use this CORT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CORT income, balance, and cash tables.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company in the Healthcare sector.
Latest cached Corcept Therapeutics Incorporated (CORT) revenue for Dec 31, 2025 was $761.4M. Net income was $99.7M. Statements: https://lician.com/financials/cort
Corcept Therapeutics Incorporated (CORT) market capitalization is $7.46B on the latest cached snapshot.
Corcept Therapeutics Incorporated (CORT) cached previous close $116.10; day range $114.55 – $117.07; volume 482,361. Session quote: https://lician.com/quote/cort
Corcept Therapeutics Incorporated (CORT) latest cached earnings event is "CORT earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CORT filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/cort